Meng Ziqing

Meng Ziqing is a full-time researcher at the Institute of Biochemistry, Academia Sinica, focusing on precision adjuvant therapy for colorectal cancer using intestinal microbial metabolites and cardiac function regulation via gut microbial metabolites for healthy aging. His work combines structural biology, clinical data analysis, and animal models to explore novel drug development strategies.

• Affiliation: Institute of Biochemistry, Academia Sinica
• Research Areas: Colorectal cancer prognosis, Gut microbiome-host interactions, Cardiac aging, Structural biology of metabolite-receptor interactions

Research Trends: His recent publications highlight S-nitrosylation mechanisms, phosphatase regulation, and microbial metabolite impacts on cancer and cardiovascular disease. Techniques include protein crystallography, post-translational modification analysis, and metabolic pathway characterization.